Adaptive Designs in Clinical Trials
24th – 25th March 2014
Holiday Inn Regents Park, London, UK
SMi is proud to present its 8th annual Adaptive Designs in Clinical Trials conference, held in central London on the 24 & 25 March 2014.
Hear through case studies how all sizes of pharmaceutical companies have successfully implemented trials incorporating adaptive designs. This conference is the only in Europe that focuses on adaptive designs specifically, providing delegates with updates on recent developments in enrichment design, dose response modelling, computer simulation, internal and external regulatory expectations and new data on evaluating adaptive dose ranging studies.
Adaptive Designs in Clinical Trials 2014 aims to show you how you can quickly and accurately implement an adaptive design clinical trial for your drug development - from initial processes in managing trials to choosing the right time to implement change
WHY ATTEND THIS EVENT:
• Learn from Michael Krams how to create an environment where adaptive designs can become the norm
• The only conference in Europe to focus specifically on adaptive designs in clinical trials
• Benefit from the first-hand experiences of speakers whose organizations have recently made breakthroughs in adaptive designs
• Hear from Vladimir Anisimov the very latest on predicative analytical techniques for increasing efficiency of drug development
• Discover at our post conference workshop how FACT software that supports the ever increasing complexity of adaptive clinical trials works, hosted by Tom Parke of Tessella
KEY SPEAKERS INCLUDE:
• Michael Krams, MD, Global Head, Quantitative Sciences, Janssen Pharmaceutical Companies of Johnson & Johnson
• Vladimir Anisimov, Senior Strategic Biostatistics Director, Quintiles
• Roger Lewis, MD, PhD, Senior Medical Scientist, Berry Consultants
• Loïc Darchy, Head of Statistical Methodology Group, Sanofi R&D
• Lilla Di Scala, Senior Statistical Scientist, Roche
• Pantelis Vlachos, Principle Biostatistician, Strategic Consulting, Cytel Corporation
• Sue Todd, Professor of Medical Statistics, University of Reading
• Frank Fleisher, Principal Statistician, Boehringer-Ingelheim
• Christopher Jennison, Professor of Statistics, University of Bath
• Graeme Archer, Statistics Director, GlaxoSmithKline
PLUS TWO INTERACTIVE POST-CONFERENCE WORKSHOPS
Workshop A: Simulating Clinical Trials using the FACTS software package: Why simulate clinical trials, how to simulate clinical trials and the difference it will make. Wednesday 26th March 2014 | Holiday Inn Regents Park, London, UK |8.30am – 1.00pm. Workshop Leader: Tom Parke, Head of Clinical Trial, Solutions, Tessella Ltd
Workshop B: Identifying and Exploiting Opportunities for Efficiency in Clinical Trial Design: An Interactive Adaptive Design Workshop. Wednesday 26th March 2014 | Holiday Inn Regents Park, London, UK | 1.00pm - 5.00pm. Workshop Leader: Professor Roger J. Lewis, MD, PhD, Senior Medical Scientist, Berry Consultants
For more information on this conference visit http://www.smi-online.co.uk/2014adaptivedesign11.asp or contact Fateja Begum on +44 (0) 20 7827 6184 or email
Strategies for Ensuring Optimum Solubility and Drug Viability
This summit investigates the core challenges to achieving maximum bioavailability in drug candidates as well as novel drug delivery solutions utilized to improve bioavailability, and expedite time-to-market of new chemical entities as well as reformulated therapeutics in the development pipeline.
For three days attendees will engage in workshops, panel discussions and case studies from distinguished representatives of companies such as Pfizer, Merck, Bristol-Myers Squibb, Astrazenenca, Regeneron and more.
The website: www.nextgenbioavailability.com
Overall the main topics and themes to be discussed include:
Date: February 20-21, 2014
Venue: San Diego, CA
The conference continues to offer presentations on novel and innovative therapeutics in ocular drug development and discovery. This forum allows for excellent networking, the exchange of ideas, and sharing of challenges; all with a united common goal of bringing new and innovative treatments to patients in the area of ophthalmology. The conference features the following topics: Session: Novel Targets, Developments and Technologies Session: Novel Drug Delivery Methods to the Anterior and Posterior Segments Session: Clinical Development Advances & Updates Session: Safety Assessment and Regulatory Landscape in Ocular Drug Development Session: Short Presentations Panel Discussion: BD, Investments and Potential for Collaborations Panel Discussion: Safety and Regulatory in Ocular Development The Ocular Diseases & Drug Development Conference promotes the discovery of ocular disease drug development by bringing together leading scientists, researchers and experts to discuss and collaborate on the latest research and development, safety assessment, regulatory issues and drugs in development for combating and curing age-related macular degeneration (AMD), diabetic retinopathy, glaucoma, DME, uveitis and other ocular diseases.
This premier conference will host an exciting group of professionals from the academic, biotech, pharmaceutical, and business communities, and will focus on drug discovery aspects within the ubiquitin pathway. A balance of both academic and industry experts will facilitate discussion on the following areas:
I. Deubiquitinating Enzymes as Drug Targets II. Novel Drug Targets in the Ubiquitin System III. Ubiquitin-like Modifications – New Opportunities IV. Ubiquitin Pathways in Neurobiology V. Ubiquitin Proteasome System and Oncology VI. Proteasome Structure and Function
OMICS Group invites all the participants across the globe to attend the 2nd International Conference and Exhibition on Food Processing and Technology during October 28-30, 2013 at Kansas city, USA.
Food Processing and Technology-2013 is a remarkable event which brings together a unique and International mix of large and medium biotech and food diagnostic companies, leading universities and Nutritional institutes making the conference a perfect platform to share experience, foster collaborations across industry and academia, and evaluate emerging technologies across the globe.
The 2nd International Conference and Exhibition on Food Processing and Technology will schedule and coordinate all meetings with our Editorial Board Members and other experts from Nutritional departments across the World. The scientific program paves a way to gather visionaries through the research talks and presentations and put forward many thought provoking strategies Food Processing and Technology.
Page 1 of 16
© 2013 Bioscreening.com